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Abstract 
Esthesioneuroblastoma is an uncommon malignant tumor of the nasal vault. Treatment consists 
of craniofacial resection. As endoscopic techniques have advanced, this approach has been 
recommended to avoid morbidity and to reduce costs. 
Aim: To evaluate outcomes in patients with esthesioneuroblastoma treated by an endoscopic 
technique. 
Methods: A prospective study of patients diagnosed with esthesioneuroblatoma and treated by 
an endoscopic technique. The literature over the past 20 years was reviewed for an update on the 
pathology. 
Results: We present 4 patients, 3 males and 1 female, staged according to Kadish and Dulguerov. 
All were treated surgically with endoscopic techniques, followed by radiotherapy. One patient was 
also submitted to neck dissection and chemotherapy because of regional metastasis. There were no 
significant postoperative complications. The mean hospital stay was 3 days; one patient stayed in 
the ICU for 24 hours after surgery. Follow-up is recent; so far there are no recurrences. 
Conclusion: Esthesioneuroblastoma is a potentially curable malignancy. Endoscopic techniques help 
reduce hospital costs and decrease the morbidity. Adequate margins of healthy tissue are obtained 
with endoscopic resection, as with craniofacial resection. The literature suggests that outcomes after 
endoscopic resection are similar to those of the conventional external approach. 
1 Médico, Residente em Otorrinolaringologia do Hospital Felício Rocho.
 
2 Médico Especialista, Otorrinolaringologista.
 
3 Médico Especialista, Otorrinolaringologista.
 
4 Médico, Residente em Otorrinolaringologia do Hospital Felício Rocho.
 
5 Médico, Residente em Otorrinolaringologia do Hospital Felício Rocho.
 
6 Médico Pediatra, Residente em Otorrinolaringologia do Hospital Felício Rocho.
 
7 Cirurgião de Cabeça e Pescoço Otorrinolaringologista, Coordenador de Clínica de Otorrinolaringologia do Hospital Felício Rocho.
 
Clínica de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço Hospital Felício Rocho.
 
Endereço para correspondência: Av. do Contorno 9530 Belo Horizonte MG 30110-934.
 
Tel: (5531) 3514-7056 - Fax: (55 31)3514-7056 E-mail: edumrm@yahoo.com.br
 
Paper submitted to the BJORL-SGP (Publishing Management System – Brazilian Journal of Otorhinolaryngology) on May 6, 2010; 
and accepted on August 16, 2010. cod. 7080 
Brazilian Journal of otorhinolaryngology 77 (2) March/april 2011 
http://www.bjorl.org / e-mail: revista@aborlccf.org.br 
171 
172 
Brazilian Journal of otorhinolaryngology 77 (2) March/april 2011 
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br 
 
  
  
      
      
        
        
        
       
      
     
 
        
      
     
  
 
     
      
      
INTRODUCTION
 
Esthesioneuroblastoma is an uncommon malig­
nancy of the nasal cavity, probably derived from epi­
thelium. This disease generally occurs between the 5th 
and 6th decades of life; a bimodal distribution (2nd and 
6th decades) has been suggested.1 Its somber histology 
has led it to be given several names; at present, two 
terms are well-established in the literature: esthesioneu­
roblastoma and olfactory neuroblastoma.2,3 It is thought 
to originate from the neuro-olfactory epithelium in the 
superior portion of the nasal cavity, the cribriform plate, 
and the upper-medial surface of the superior turbinate.1 
This site generally means that symptoms may be non­
specific, resulting in diagnoses made at more advanced 
phases of the disease (involvement of facial sinuses and 
the anterior cranial fossa).4 
This tumor comprises about 6% of cases of 
paranasal sinus and nasal cavity cancers, and 0.3% of 
upper aerodigestive tract cancers. About 1,000 cases 
have been published to date since its first description 
by Berger et al.5 
Management of this tumor is uncertain because 
of the paucity of cases and advances in diagnostic and 
treatment methods. Current approaches include en bloc 
surgery, single or combined endoscopic procedures, 
radiotherapy, and chemotherapy. Although en bloc 
surgery is considered the standard treatment, it has re­
latively high postoperative morbidity (about 35%) and 
mortality (about 2-5%), which has led to a search for 
new approaches.6 Because of increasing command of 
endoscopic techniques in the nose, these approaches 
have been advocated to reduce morbidity and costs.7 
The purpose of this study was to report the 
experience of our institution in the treatment of this 
malignancy with endoscopic techniques. 
METHODS
 
A historical cross-sectional cohort study was car­
ried out at a tertiary level hospital in Belo Horizonte, 
Minas Gerais state, Brazil, from December 2008 to the 
present date, August 2010. The institutional review 
board approved the study (number 323/10). 
Patients diagnosed with esthesioneuroblastoma 
by histological and immunohistochemical studies of 
biopsy samples, and candidates for surgery were in­
cluded in our study. The sample comprised 4 patients 
(3 male and 1 female) aged from 22 to 46 years (mean 
33 years). Computed tomography (CT) and magnetic 
nuclear imaging (MRI) of the facial sinuses was carried 
out in all patients for surgical planning. Surgical risk 
assessment was done and a plain chest radiograph was 
taken to investigate possible metastases. Tumors were 
staged according to the Kadish et al.8 and Dulguerov9 
& Calcaterra criteria (Tables 1 and 2). 
Table 1. Staging system according to Kadish et al. and Morita 
et al. 
TYPE EXTENT 
A Tumor is limited to the nasal cavity 
B 
Tumor in the nasal cavity and extending to the paranasal 
sinuses 
C 
Tumor extends beyond the nasal cavity and paranasal 
sinuses, involving the cribriform lamina, the skull base, the 
orbit, or the intracranial cavity 
D Tumor with neck or distant metastases 
Source: Kadish et al. e Morita et al.8
 
Table 2. Staging system according to Dulguerov et al.
 
STAGE FEATURES 
Tumor involving the nasal cavity and/or paranasal 
T1 sinuses (excluding sphenoid), sparing the most supe-
rior ethmoidal cells 
Tumor involving the nasal cavity and/or paranasal 
T2 sinuses (including the sphenoid), with extension to or 
erosion of the cribriform plate 
Tumor extending into the orbit or protruding into the 
T3 
anterior cranial fossa, without dural invasion 
T4 Tumor involving the brain 
N0 No cervical lymph node metastasis 
N1 Any form of cervical lymph node metastasis 
M0 No metastasis 
M1 Distant metastases present 
Source: Dulguerov9 & Calcaterra 
Patients underwent nasosinusal endoscopic sur­
gery to remove the primary tumor; they were informed 
of the possibility of open surgery if the endoscopic 
approach was deemed unsatisfactory. A neurosurgery 
team was ready to intervene if necessary. 
Patients were under general anesthesia with 
controlled hypotension; the head was elevated to 
reduce bleeding. Local vasoconstriction was attained 
with cottonoids imbibed in a 1:5000 adrenalin solution, 
infiltration with xylocaine + 1:100.000 adrenalin, and a 
10-minute waiting period. Rigid 4 mm diameter 25 and 
45 degree telescopes were used. At first the intranasal 
tumor mass was debulked to identify the pedicle, as 
this neoplasm is expansive, rather than infiltrative. 
The pedicle was then removed with macroscopic free 
173 
Brazilian Journal of otorhinolaryngology 77 (2) March/april 2011 
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br 
      
  
     
       
       
          
       
          
       
       
        
    
       
      
         
     
          
     
      
     
       
     
       
      
        
      
       
     
margins, including the mucosa and bony lamina. The 
lamina papyracea, cribriform lamina, the lacrimal bone, 
and the posterior septum were removed if appropriate 
according to the type of lesion. Cottonoid and electro­
cautery hemostasis was performed. A bipolar cautery 
was used preferentially in the base of skull and orbit. 
A mucoperichondrial septal reconstruction flap for the 
posterior base, described by Hadad, et al.10 was used 
when there was ample exposure of the anterior base of 
skull. Anterior unilateral tamponade was used for 24 to 
72 hours. Nasal cavities were cleaned postoperatively 
with saline; crusts were removed in the outpatient unit. 
Supplementary postoperative radiotherapy was 
indicated routinely and started from three to four we­
eks postoperatively. Adjuvant chemotherapy was used 
in one special case where there was a higher risk of 
systemic dissemination of the disease. 
Nasosinusal endoscopy and imaging (CT and 
MRI) were used in the postoperative follow-up. Both 
were done after careful hygiene of the nasosinusal 
cavities and treatment of infection, if present. Biopsies 
from tumor sites and/or suspected areas were taken 
during endoscopy. A plain chest radiograph was done 
every six months. Survival was not evaluated because 
the follow-up period was short for a conclusive report. 
RESULTS
 
Epidemiology and Staging 
All patients complained of progressive nasal blo­
ck ipsilateral to the tumor, and intermittent headaches. 
One patient had lateral displacement of the orbit and 
diplopia; another patient had bilaterally enlarged neck 
lymph nodes. Inspection revealed a reddish intranasal 
tumor that bled when manipulated. Three patients were 
biopsied at our unit. One patient was referred to us with 
complete histological results. Biopsies were done in the 
outpatient and hospital settings. There was moderate 
to intense nasal bleeding, which was controlled with 
anterior tamponade for 24 hours. 
CT was relevant for surgical planning; it showed 
the anatomy of the facial bones and eventual bony ero­
sions. MRI was employed to assess the true extent of the 
tumor and to help differentiate neoplastic tissue from 
secondary sinus disease. MRI was used also to evaluate 
intracranial and orbitary involvement, and to establish 
whether there was infiltration or only displacement of 
these structures because of tumor growth. 
Two patients were stage Kadish B and Dulguerov 
T1N0; one patient was stage Kadish C and Dulguerov 
T3N0; one patient was stage Kadish D and Dulguerov 
T2N1 (Table 3). 
Treatment 
The same surgical team - experienced in cranio­
facial resection and nasosinusal endoscopy - carried out 
the procedures. Endoscopic resection of the primary 
tumor with equivalent margins to those of open surgery 
was possible in all patients. There was no need for the 
neurosurgical team to intervene in any case; the pre­
sence of this team in the operating room was important 
for safety and to provide guidance in cases where the 
cranial base was more involved. 
After debulking, although nasosinusal tumors 
could appear large, the infiltrative portion was pro­
portionally smaller and generally limited to the lateral 
or superior walls of the ethmoid. The infiltrated areas 
were removed and sent separately to the pathology 
department; margins were assessed, and were free. 
Intraoperative frozen sections were not carried out. 
The anterior cranial base had to be opened - with 
exposure of the brain - in one patient. It was recons­
tructed with temporal fascia and a posterior nasoseptal 
rotation (described by Hadad et al.).10 
The patient with neck metastases underwent 
bilateral neck dissection and temporary tracheostomy, 
and was the only patient that was sent to the intensive 
care unit in the immediate postoperative period. 
The hospital stay was from 2 to 5 days. All patients 
were treated with postoperative supplementary external 
radiotherapy, which was started in the third to fourth 
week after surgery. The patient with neck metastases 
underwent chemotherapy with radiotherapy, as the risk 
of dissemination of the disease was higher in this case. 
Complications after surgery 
The postoperative morbidity related to endoscopy 
was minor. There were no significant complications 
such as bleeding, meningitis, cerebrospinal fluid leak, or 
altered vision. Two patients developed non-obstructive 
intranasal synechiae due to therapy. All patients had 
intranasal crusts for prolonged periods. The patient that 
underwent neck dissection presented a cervical node 
during follow-up; it was removed and diagnosed as an 
inflammatory granuloma, probably suture-related. 
Follow-up 
Postoperative follow-up ranged from 7 to 17 
months (mean - 14 months). Until the present time 
no tumors have recurred. One patient has not made 
the regular visits because of the distance between the 
hospital and the patient’s household (Amapá state). 
The remaining three patients have been controlled with 
postoperative imaging and nasosinusal endoscopy with 
multiple biopsies; these were negative. 
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Table 3. Data on patients, treatment and follow-up. 
Patient Age (years) Sex Kadish Dulguerov Treatment Follow-up (months) 
IGM 40 M C T3N0 RE + RT 17 
JPP 29 M D T2N1 RE + ECB + RT + QT 17 
ASM 46 M B T1N0 RE + RT 15 
LMTP 22 F B T1N0 RE + RT 7 
Key: RE= endoscopic resection, RT= radiotherapy, ECB= bilateral neck dissection, QT= chemotherapy 
Source: own data 
DISCUSSION
 
Esthesioneuroblastoma is an uncommon disease; 
its symptoms are similar to those of common condi­
tions, such as chronic sinusitis and nasal polyps, which 
complicates an early diagnosis. The main reported 
symptoms in our series were nasal block and headache; 
contrary to other papers,11-13 epistaxis was infrequent. 
The differential diagnosis is made with other nasosinusal 
tumors, such as the inverted papilloma and squamous 
cell carcinomas.14 An early biopsy is recommended in 
suspect lesions; this procedure is done after tomogra­
phy of the facial sinuses, which provides guidance for 
the biopsy site and helps reduce the complication rate. 
Biopsies should be done in a hospital setting because 
of the risk of hemorrhage and the need for aggressive 
tamponade. The histological characterization of esthe­
sioneuroblastoma is difficult; in general, immunohisto­
chemical methods are employed3 (Fig. 1). 
Figure 1. Histology and immunohistochemistry of a surgical specimen 

(esthesioneuroblastoma).
 
Key: HE-stained histology of a surgical specimen (a) and positive 

immunohistochemistry for S-100 (b) and synaptophysin (c) markers.
 
Source: own data.
 
We applied the Kadish et al. and Dulguerov & 
Calcaterra staging method in our patients. These criteria 
are based on preoperative image exams (CT and MRI) 
to inform the surgeon on the method and prognosis, 
and to support publishing and research. There is no 
consensus in the literature about which method is best. 
A few series appear to suggest that the Dulguerov sys­
tem is more accurate in predicting survival.9 There is 
a further staging method proposed by Hyams,15 which 
is based on the histology of the disease. Staging yields 
prognostic information, and ranges from I to IV; grade 
I refers to patients with good follow-up, and grade IV 
refers to patients who die because of the disease. Re­
gardless of the staging method, published papers show 
that the prognosis is worse in proportion to the extent 
of the tumor, local invasion, and regional or distant me­
tastases, regardless of the treatment.16 Our study shows 
that different staging approaches may be successfully 
adopted for esthesioneuroblastoma in endoscopy. 
In our experience, MRI was useful to: 1) establish 
the true extent of the disease and its infiltrative or com­
pressive nature relative to the orbit and the intracranial 
area; and 2) to differentiate this cancer from secondary 
sinus disease (Fig. 2). Such information was essential 
for endoscopic surgery planning, but did not assure that 
procedures would be successful. The possibility of open 
surgery should be considered, and the surgical team 
should be prepared for this option. A multidisciplinary 
team - including a neurosurgeon - is paramount for 
advances in endoscopic surgery relative to procedures 
in the skull base. Although the neurosurgical team was 
not required in our series, the presence or availability of 
these professionals increase our sense of safety during 
surgery and when dealing with postoperative events. 
One of our patients, staged as Kadish C, presented CT 
and MRI images suggesting invasion of the orbit and 
anterior skull base (Fig. 3). During surgery, the orbit 
was not invaded and the lamina cribosa was involved 
but without invasion of the dura. There are reports of 
poor correlation between preoperative CT and MRI and 
intraoperative findings relative to other nasal tumors, 
such as in advanced stages of the nasoangiofibroma.17 
This has not been described or investigated in esthe­
sioneuroblastoma cases. 
Significant advances have taken place in nasosi­
nusal endoscopy in the past few years. At first, endos­
copy was used for the surgical treatment of infection 
and inflammatory processes. As proficiency in the 
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 Figure 2. Preoperative CT and MRI of the patient JPP; stage Kadish 

D and Dulguerov T2n1.
 
Source: own data.
 
Figure 3. Preoperative CT and MRI of patient IGM, stage Kadish C 

and Dulguerov T3n0.
 
Source: own data.
 
techniques increased and appropriate materials were 
developed, new applications arose, such as endoscopic 
dacryocystorhinostomy, inferior-medial decompression 
of the orbit, endoscopic closure of cerebrospinal fluid 
leaks, among others. The possibilities for endoscopy 
seem unlimited. 
At present, endoscopic techniques have been 
applied to the treatment of nasosinusal and skull base 
neoplasms.7,10,18-20 The indications and limitations of 
these techniques remain controversial, and need to 
be further defined, not only what may be done, but 
especially when. 
Stammberger et al.18 first published (in the English 
literature) their experience with endoscopic treatment of 
nasal malignancies, including esthesioneuroblastomas. 
Endoscopic resection is indicated for tumors contained 
within the nostrils and paranasal cavities not deeply 
infiltrated into the orbit, the pterygopalatine fossa, or 
the posterior wall of the frontal sinuses.7,18 Preoperati­
ve CT and MRI are essential for surgical planning.11-12 
Minor complications such as cerebrospinal fluid leaks 
and intraorbitary hemorrhage have been described in 
this technique; the risk is similar to that of endoscopy 
in chronic sinusitis.7 
Several authors still defend en bloc craniofacial 
resection as the treatment of choice for tumors in ge­
neral.21,22 The rationale is that this traditional technique 
yields safer free margins and consequently fewer recur­
rences, as well as a more reliable reconstruction of the 
skull base. This procedure, however, is surgically trau­
matic; healthy structures are resected to provide access 
to the surgical field, the duration of surgery is longer, 
and intensive postoperative care is required. Cerebros­
pinal fluid leaks, frontal abscesses, pneumocephalus, 
hydrocephalus, intracranial hemorrhage, subdural he­
matoma and hygroma, mucoceles, diabetes insipidus, 
and amaurosis due to thromboembolic disease have 
been described as complications of open surgery.23,24 
These complications are potentially avoidable when 
using endoscopy. In our opinion, an open approach 
should be employed in selected cases where there is 
significant local invasion. 
Two points need to be demonstrated for endos­
copic techniques to be accepted in the treatment of 
nasosinusal tumors. Firstly, the technique should not 
compromise the radicality of resection, and recurren­
ces should be similar to the conventional technique. 
Secondly, it should have significant advantages relati­
ve to the conventional technique. We believe this is 
the case in the treatment of esthesioneuroblastomas. 
As seen in our series, this tumor is more expansive 
than infiltrative. After debulking, it was clear that the 
infiltrated area - and thus the origin of the tumor - is 
relatively small compared to the total extent of the 
tumor. En bloc craniofacial resection would have sacri­
ficed healthy tissues in our cases, but would not have 
increased the safety margins. Meticulous removal of 
the area of interest - the tumor site - is possible with 
endoscopic surgery. Other advantages of endoscopic 
over conventional surgery are: 1) it avoids retraction of 
frontal lobes, 2) it avoids esthetic and functional loss 
because of transfacial approaches, 3) it allows difficult 
areas to be visualized, and 4) it reduces the recovery 
period and hospital stay of patients. The skull base may 
be reconstructed endoscopically, if needed. 
Radiotherapy was used in all cases, as would 
have been done if patients had undergone craniofacial 
resection. The proximity of noble structures - the brain 
and the orbit - does not allow ample safety margins, 
which justifies routine adjuvant radiotherapy. Two me­
thods may be used: the external conventional or guided 
stereotaxic approaches. Compared to the conventional 
method, stereotaxic radiotherapy was superior in the 
treatment of esthesioneuroblastoma because of more 
effective local action and lower morbidity.25 At present, it 
is indicated - as presented in the literature - for patients 
where surgical resection was incomplete or residual 
disease is present.26 A few authors have recommended 
this treatment in advanced stages of the disease (Kadish 
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B or D) even after complete resection, for improved 
local control.27 Its use alone is not recommended; pu­
blished papers have shown that survival is increased 
when combined therapy is used.28 In spite of these ad­
vances in surgery and radiotherapy, local and regional 
recurrence remains a major challenge.29 
Neck metastases may be found in up to 5% of 
patients at the diagnosis.12 These patients require neck 
dissection and/or radiotherapy. A review of the litera­
ture revealed that up to 23% of patients may have neck 
lesions as the disease progresses.30 Management of 
negative necks in esthesioneuroblastomas is controver­
sial; some authors have suggested that radiotherapy or 
elective neck dissection is required, especially if there is 
significant local invasion.30 Furthermore, when clinically 
apparent, the presence of enlarged neck lymph nodes is 
associated with distant metastases.31 However, as neck 
disease may take about two years to develop, most 
authors do not recommend elective treatment of a ne­
gative neck.32 Regional and distant metastases drastically 
reduce survival. The high rate of regional metastases 
described in the literature contradicts the statement that 
esthesioneuroblastomas are tumors with low malignant 
potential.33 The patient that was staged Kadish D and 
Dulguerov T2N1 in our sample was treated according to 
the protocol of renowned international institutions.10,30 
Our follow-up period is short and the sample 
is small for survival calculations and the prognosis. At 
this time, no tumor has recurred, and the success of 
intraoperative endoscopic resection is encouraging. As 
in other series, this fact suggests a promising future for 
this approach. 
CONCLUSION
 
Esthesioneuroblastoma is a potentially curable 
malignancy with surgery and radiotherapy. Endoscopic 
techniques result in significant esthetic and functional 
gains, reduced recovery times, lower costs, and less 
morbidity and mortality compared to the conventional 
approach. It is possible with endoscopy to attain similar 
margins to those of conventional surgery. Long term 
results, as described in the literature, are similar to those 
of the conventional treatment. Our follow-up is short, 
not allowing any conclusion on the prognosis. 
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